Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2953.05 (Glytoucan)

Id:a5b2d22f-7323-54d5-8eb1-30cc3a387609

Glytoucan:G89531JR

Results found

Linked to

	Label	Description
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G16444FW-GLYCOSEQ00023371 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G98565KP-GLYCOSEQ00180449 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G17483AZ-GLYCOSEQ00080852 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G06594DV-GLYCOSEQ00135542 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has canonical residue n-glycan a-d-neupnac 14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G94973XS-GLYCOSEQ00181213 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000119 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G22728HO-GLYCOSEQ00084617 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G16444FW-GLYCOSEQ00023371 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G98565KP-GLYCOSEQ00180449 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G17483AZ-GLYCOSEQ00080852 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G06594DV-GLYCOSEQ00135542 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has canonical residue n-glycan a-d-neupnac 14

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G94973XS-GLYCOSEQ00181213 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000119 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2953.05 has glycosequence GLYGEN.GLYCOSEQUENCE:G22728HO-GLYCOSEQ00084617 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.